Phreesia Inc (PHR) concluded trading on Thursday at a closing price of $23.97, with 0.49 million shares of worth about $11.65 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 13.98% during that period and on April 17, 2025 the price saw a gain of about 0.33%. Currently the company’s common shares owned by public are about 58.73M shares, out of which, 53.73M shares are available for trading.
Stock saw a price change of -0.13% in past 5 days and over the past one month there was a price change of -17.34%. Year-to-date (YTD), PHR shares are showing a performance of -4.73% which increased to 4.22% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $17.07 but also hit the highest price of $30.53 during that period. The average intraday trading volume for Phreesia Inc shares is 494.08K.
Phreesia Inc (NYSE: PHR) currently have 58.73M outstanding shares and institutions hold larger chunk of about 92.99% of that.
The stock has a current market capitalization of $1.41B and its 3Y-monthly beta is at 0.75. It has posted earnings per share of -$1.02 in the same period. It has Quick Ratio of 1.78 while making debt-to-equity ratio of 0.07. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for PHR, volatility over the week remained 4.31% while standing at 5.65% over the month.
Stock’s fiscal year EPS is expected to rise by 76.71% while it is estimated to increase by 191.89% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by RBC Capital Mkts on January 08, 2025 offering an Outperform rating for the stock and assigned a target price range of between $24 and $32 to it. Coverage by Truist stated Phreesia Inc (PHR) stock as a Buy in their note to investors on February 26, 2024, suggesting a price target of $35 for the stock. On January 17, 2024, DA Davidson Upgrade their recommendations, while on January 03, 2024, Barclays Initiated their ratings for the stock with a price target of $29. Stock get an Overweight rating from Stephens on April 12, 2023.
